Alere Posts Loss On Charges, But Tops View; Shares Down 7%

Alere Inc. (ALR) Monday posted a loss for the first-quarter hurt mainly by one-time charges. Nevertheless, excluding special items, adjusted profit for the quarter improved and as well trumped expectations, on stronger than anticipated revenues. Shares of Alere fell seven percent following the news on the New York Stock Exchange.

Massachusetts-headquartered Alere posted first-quarter net loss available to stockholders of $4.1 million or $0.05 per share, compared to a profit of $8.09 million or $0.09 per share last year.

For the first quarter, the company recorded an amortization charge of $78.1 million, $5.6 million of restructuring charges, $3.9 million of stock based compensation expenses, among a few other items.

Adjusted cash-basis net income improved to $0.77 per share from $0.61 last year. On average, 11 analysts polled by Thomson Reuters expected earnings of $0.67 per share for the quarter. Analysts' estimates typically exclude special items.

Alere said its revenues for the quarter grew to $671.13 million from $582.46 million last year. Adjusted net revenue was $672.42 million for the quarter. Analysts expected revenues of $659.34 million for the quarter.

Adjusted product and services revenues from Professional Diagnostics segment rose to $516.7 million for the quarter from $409.8 million last year, helped mainly by recent professional diagnostics acquisitions.

Product and services revenue from Health Management segment dropped to $130.8 million from $143.1 million last year, due primarily to the insourcing of certain services by large health plans.

ALR is currently trading at $23.89, down $1.78 or 6.95%, on a volume of 1.1 million shares.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Frozen Food Development is recalling specific lots of Lidl branded 12-ounce packages of Frozen Chopped Spinach citing the potential to be contaminated with Listeria monocytogenes, the U.S. Food and Drug Administration said. The product comes in 12-ounce poly bags, and items included in the recall are marked with lot # R17742 or R17963 on the back of the poly bag with a best by date of 09/10/23. Starbucks has dropped its vaccine or weekly test requirement against Covid-19 for U.S. employees in the wake of last week's U.S. Supreme Court ruling. The court, in a 6-3 vote, has blocked President Joe Biden's vaccine-or-test mandate for private companies with 100 or more employees. However, it allowed the vaccine mandate to stand for certain health care workers. Mylan Pharmaceuticals Inc., affiliated to healthcare company Viatris Inc., is recalling one batch of its non-interchangeable Semglee (insulin glargine injection), 100 units/ml (U-100), 3mL prefilled pens due to the potential for a missing label, the U.S. Food and Drug Administration said.
Follow RTT